Hyperthermia is a type of medical treatment in which selected organs or the entire body are exposed to elevated temperatures through the action of exogenous heat sources, capable of breaking the patient’s natural thermoregulation. Research has shown that high temperatures can damage and kill cancer cells, usually with minimal injury to normal tissues. Higher temperatures selectively damage cells that are hypoxic and have low pH, a condition of tumor cells and not a condition of normal cells. Hyperthermia has been shown to inhibit cellular repair mechanisms, induce heat-shock proteins, denature proteins, induce apoptosis, and inhibit angiogenesis.
Apart from a few procedures such as HIPEC, hyperthermia as a method of cancer treatment is characterized by extremely low toxicity – it does not leave any chemicals in the body and is not radioactive. Therefore, its addition to oncological treatment protocols does not increase the risk of side effects or increases them very slightly.
Detailed information about scientific and clinical evidence in favour of hyperthermia is included on our webpage SCIENCE & RESEARCH, while a selection of specific publications and professional literature on hyperthermia is found in the section BIBLIOGRAPHY.
Celsius TCS uses a technology called capacitive. This name is related to the fact that the patient’s body, and more precisely his tissues, plays the role of a resistor (capacitor) in relation to the electromagnetic field excited between two active electrodes.
ul. Belgradzka 5
02-793 Warszawa, Poland
+48 22 300 91 85
Monday - Tuesday
from 8 a.m. to 6 p.m.